Lahav M, Ne'eman N, Sela M N, Ginsburg I
Inflammation. 1979 Sep;3(4):365-77. doi: 10.1007/BF00913495.
The bactericidal and bacteriolytic effects of lysolecithin (LL) and egg-white lysozyme (LYZ) on Staph. aureus and group A streptococci and the solubilization of phospholipids from the bacterial membranes by these agents was studied. Low concentrations of lysolecithin (1--10 microgrames/ml) are highly bactericidal for Steph. aureus and group A streptococci, but induce neither bacteriolysis nor solubilization of a substantial amount of membrane phospholipids. On the other hand, while LL at greater than 50 micrograms/ml causes substantial lipid release, a combination of LL and LYZ is absolutely needed to solubilize lipids from streptococci. This combination is, however, not bacteriolytic for this microrganism. The solubilization of lipids from staphylococci by LL is much faster than that induced in streptococci by LL + LYZ. The solubilization of the bulk of membrane lipids from staphylococci can also be achieved by Triton X-100 and by sodium lauryl sulfate and from group A streptococci by Triton X-100 plus LYZ. A variety of other detergents (e.g., Cetavlon, sodium taurocholate, cetyl pyrdinium chloride) have no lipid-releasing properties even in the presence of LYZ. The release of lipids by LYZ (in the presence of LL) from group A streptococci is related to its enzymatic activity, on a still unknown substrate, but not to its cationic nature as this muramidase cannot be replaced by a variety of cation substances (histone, polylysin, leukocyte cationic proteins, polymyxin B, and spermidine). The release of lipids from staphylococci by LL is not inhibited by a variety of anionic and cationic polyelectrocytes (heparin, liquoid, chondroitin sulfate, DNA histone, and polylysine) which markedly inhibit the release of lipids from group A streptococci by LL and LYZ. Streptococci that had been cultivated in the presence of subinhibitory concentrations of penicillin G lose their membrane phospholipids to a larger extent and by much smaller concentrations of LL and LYZ, as compared to controls, suggesting that the interference with the synthesis of the peptidoglycan increases the accessibility of the cell membrane to the lipid-releasing agents. The mechanism by which LL collaborates with LYZ in lipid release is still not known. The possible role of bacterial lipids and lyso compounds in the control of bacterial survival in inflammatory sites is briefly discussed.
研究了溶血卵磷脂(LL)和蛋清溶菌酶(LYZ)对金黄色葡萄球菌和A组链球菌的杀菌和溶菌作用,以及这些试剂对细菌膜磷脂的溶解作用。低浓度的溶血卵磷脂(1-10微克/毫升)对金黄色葡萄球菌和A组链球菌具有高度杀菌作用,但既不诱导细菌溶解,也不使大量膜磷脂溶解。另一方面,虽然浓度大于50微克/毫升的LL会导致大量脂质释放,但要从链球菌中溶解脂质,绝对需要LL和LYZ的组合。然而,这种组合对这种微生物没有溶菌作用。LL从葡萄球菌中溶解脂质的速度比LL+LYZ从链球菌中诱导溶解脂质的速度要快得多。Triton X-100和十二烷基硫酸钠也能使葡萄球菌的大部分膜脂质溶解,Triton X-100加LYZ能使A组链球菌的膜脂质溶解。多种其他去污剂(如西他氯铵、牛磺胆酸钠、十六烷基氯化吡啶)即使在有LYZ存在的情况下也没有脂质释放特性。LYZ(在有LL存在时)从A组链球菌中释放脂质与其在一种仍未知的底物上的酶活性有关,而与其阳离子性质无关,因为这种溶菌酶不能被多种阳离子物质(组蛋白、聚赖氨酸、白细胞阳离子蛋白、多粘菌素B和亚精胺)替代。LL从葡萄球菌中释放脂质不受多种阴离子和阳离子聚电解质(肝素、利可君、硫酸软骨素、DNA组蛋白和聚赖氨酸)的抑制,而这些聚电解质能显著抑制LL和LYZ从A组链球菌中释放脂质。与对照组相比,在亚抑制浓度的青霉素G存在下培养的链球菌会在更大程度上失去其膜磷脂,且所需的LL和LYZ浓度要小得多,这表明对肽聚糖合成的干扰增加了细胞膜对脂质释放剂的可及性。LL与LYZ协同释放脂质的机制仍不清楚。简要讨论了细菌脂质和溶菌化合物在炎症部位控制细菌存活中的可能作用。